Other new biomarkers of SCD are magnesium [92], which is a membrane stability regulator whose levels are inversely associated with SCD, and cystatin C, a marker of renal failure, inflammation and atherosclerosis [93]. The gene discussed is CST3; the disease is Schnyder corneal dystrophy.